[Pharmacological study of phthalazino-(2,3-b)-phthalazine-5 (14H), 12(7H)-dione (L-5418)].
D000698:Analgesia; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001172:Arthritis, Rheumatoid / Q000517:prevention & control; D001241:Aspirin / Q000494:pharmacology; D001463:Barbiturates / Q000494:pharmacology; D001777:Blood Coagulation / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002199:Capillary Permeability / Q000187:drug effects; D004064:Digestive System / Q000187:drug effects; D004357:Drug Synergism; D004487:Edema / Q000188:drug therapy; D004890:Erythema / Q000188:drug therapy; D005260:Female; D005439:Flufenamic Acid / Q000494:pharmacology; D006099:Granuloma / Q000517:prevention & control; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009068:Movement / Q000187:drug effects; D010653:Phenylbutazone / Q000494:pharmacology; D010793:Phthalazines / Q000494:pharmacology*; D011724:Pyridazines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats
D000893:Anti-Inflammatory Agents; D001463:Barbiturates; D010793:Phthalazines; D011724:Pyridazines; D005439:Flufenamic Acid; D010653:Phenylbutazone; D001241:Aspirin